Press

FILTER:

Meet the MicroArch D1025 High-Precision Micro 3D Printer

From healthcare to manufacturing to aerospace, so many industries need highly precise tiny parts. Boston Micro Fabrication (BMF) uses micro-stereolithography (PµSL) technology in its line of printers, boasting fast production times and resolutions between an astonishing 2µm and 50µm.

A 3D Printing Industry Oasis in the Heart of an Urban Wasteland

We had a great time showing off our new D1025 Dual Resolution 3D printer and chatting about industry trends with our colleagues last week at RAPID + TCT 2024! Our CEO, John Kawola, spoke with Matt Kremenetsky of 3DPrint.com about how advances in material science are increasingly driving 3D printing applications and how our precise micro-printers make parts that are indispensable to various industries.

Enabling Unique Applications with Micro-Precision 3D Printing

The demand for 3D printing continues to grow as trends of miniaturization create opportunities for innovation across industries from electronics to dental to biotechnology. Our CEO, John Kawola, recently sat down with Laura Griffiths from The TCT Group to discuss what he’s learned in his career in the 3D printing industry, plus insights on recent news - from the launch of BMF Biotechnology to the release of the new microArch D1025 printer.

Fast 50 (Fastest-Growing Private Companies in Mass.)

This year's list includes the 50 privately held, Massachusetts-based/co-headquartered businesses that recorded the highest revenue growth from 2020 to 2023. To be considered, companies needed a baseline of $1 million in revenue for 2023 and at least $500,000 in revenue for 2020. In some cases, 2023 revenue numbers are projections, as provided to the BBJ at the time of the submission. Companies that did not record revenue growth from 2022 to 2023 were disqualified.

BMF’s Roadmap to Success

As micro 3D printing continues to aid innovation in medtech and lifesciences, researchers are working on ways to standardize the technology for industry-wide use. Our CEO John Kawola recently spoke with Oliver Johnson from Med-Tech Innovation about our work with the Centre for Additive Manufacturing (CfAM) at University of Nottingham. They are using our platform to make samples for next-generation medical devices and simultaneously developing a playbook for the use of additive manufacturing in medtech that can help advance regulatory pathways for these devices.

Boston Micro Fabrication Launches Industry’s First Hybrid Micro-Precision 3D Printer Series

To offer more flexibility for customers looking for high precision 3D printing solutions, Boston Micro Fabrication (BMF) is launching the industry’s first line of hybrid printing solutions for micro-scale and ultra high-resolution applications. The dual resolution microArch D1025 is the first printer in the series, printing in either 10µm or 25µm resolution, or in hybrid mode with both resolutions in the same print layer or in different layers.

Industry Voices: Is Micro-3D Printing the Future for Tiny Parts?

Across industries from life sciences to electronics, ultra-high resolution and precision parts are often required for innovation – especially when that innovation is driven by miniaturization. As products and technology get smaller, so do the intricacies of the parts that are the sum of the whole. Many engineers and product designers are turning to 3D printing to manufacture these highly precise, small-scale parts. Additive manufacturing is lately proving to be an efficient option when compared to traditional molding.

Boston Micro Fabrication Launches BMF Biotechnology Inc. to Advance Use of 3D BioChips in Pharmaceutical and Cosmetic Research

To better support the use of highly precise, microfluidic solutions in advanced drug development, pharmaceutical and cosmetic research, Boston Micro Fabrication (BMF) proudly introduces BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercializing innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.